Company Gottlieb Pharmaceuticals Srl with Fiscal Code 26381057
recorded a turnover of 2024 of
30.803.096,
with a net profit of
6.153.394
and having an average number of employees of
8.
The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Gottlieb Pharmaceuticals Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
2.030.834
7.515.379
11.702.411
8.077.290
7.129.279
13.492.300
13.705.271
15.535.182
18.380.279
30.803.096
Total Income - EUR
2.036.628
7.519.006
11.755.598
8.084.656
7.130.294
13.538.607
13.735.085
15.535.308
18.421.795
30.878.885
Total Expenses - EUR
1.756.570
5.670.952
9.076.421
6.232.792
5.492.612
10.544.181
11.085.837
9.755.780
13.703.077
23.588.210
Gross Profit/Loss - EUR
280.058
1.848.054
2.679.178
1.851.864
1.637.682
2.994.426
2.649.248
5.779.528
4.718.718
7.290.675
Net Profit/Loss - EUR
233.464
1.551.973
2.249.940
1.555.218
1.375.441
2.514.007
2.233.191
4.993.518
3.978.818
6.153.394
Employees
5
5
5
5
5
6
6
7
6
8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 68.5%, from 18.380.279 euro in the year 2023, to 30.803.096 euro in 2024.
The Net Profit increased by 2.196.813 euro, from 3.978.818 euro in 2023, to 6.153.394 in the last year.
Check the financial reports for the company - Gottlieb Pharmaceuticals Srl
Financial Rating - GOTTLIEB PHARMACEUTICALS SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Gottlieb Pharmaceuticals Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Gottlieb Pharmaceuticals Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Gottlieb Pharmaceuticals Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Gottlieb Pharmaceuticals Srl - CUI 26381057
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
11.371
8.850
7.484
25.743
19.938
18.704
11.867
8.104
32.536
52.691
Current Assets
736.138
1.630.026
2.489.023
1.795.492
1.411.976
2.621.078
2.468.321
5.574.867
8.290.952
8.847.911
Inventories
4.396
44
61.295
230.870
43.263
41
138.162
219.020
1.197.349
1.218.945
Receivables
85.733
144.418
265.098
133.314
130.230
263.759
245.057
2.337.442
3.243.322
5.799.862
Cash
646.009
1.485.564
2.162.631
1.431.308
1.238.483
2.357.278
2.085.102
3.018.405
3.850.281
1.829.105
Shareholders Funds
434.270
1.552.240
2.250.202
1.555.476
1.375.694
2.514.255
2.233.433
4.993.964
3.979.303
6.153.877
Social Capital
225
223
219
215
211
207
202
406
404
402
Debts
313.240
86.636
246.305
265.760
59.351
128.597
249.757
589.007
4.367.787
2.746.725
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
8.847.911 euro in 2024 which includes Inventories of
1.218.945 euro, Receivables of
5.799.862 euro and cash availability of
1.829.105 euro.
The company's Equity was valued at
6.153.877 euro, while total Liabilities amounted to
2.746.725 euro.
Equity increased by 2.196.813 euro, from 3.979.303 euro in 2023, to 6.153.877 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Gottlieb Pharmaceuticals Srl